Cart
sales@molnova.com
HIF1-IN-3?
CAS No. 333314-79-7
HIF1-IN-3?( Benzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]- )
Catalog No. M28955 CAS No. 333314-79-7
HIF1-IN-3 is an effective inhibitor of HIF-1 (EC50 = 0.9 μM) and can be used in anticancer studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 5MG | 36 | In Stock |
|
| 10MG | 55 | In Stock |
|
| 25MG | 112 | In Stock |
|
| 50MG | 207 | In Stock |
|
| 100MG | 286 | In Stock |
|
| 200MG | 414 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHIF1-IN-3?
-
NoteResearch use only, not for human use.
-
Brief DescriptionHIF1-IN-3 is an effective inhibitor of HIF-1 (EC50 = 0.9 μM) and can be used in anticancer studies.
-
DescriptionHIF1-IN-3 is an effective inhibitor of HIF-1 (EC50 = 0.9 μM) and can be used in anticancer studies.
-
In Vitro——
-
In Vivo——
-
SynonymsBenzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]-
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorSIRT2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number333314-79-7
-
Formula Weight412.5
-
Molecular FormulaC26H24N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (303.04 mM)
-
SMILESO=C(NC(C1=CC=C2C=CC=NC2=C1O)C3=CC=C(OC)C=C3)CCC4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schiedel M, et al. Structure-Based Development of an Affinity Probe for Sirtuin 2. Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2252-6.
molnova catalog
related products
-
2-Methoxyestradiol
2-Methoxyestradiol (2ME2;NSC-659853) is a metabolite of estradiol-17β and a novel antimitotic, antiangiogenic agent.
-
IOX4
IOX4 (PHD2 inhibitor IOX4) is a potent, selective inhibitor of prolyl hydroxylase domain enzyme PHD2 with IC50 of 1.6 nM.
-
PT2385
PT2385 (PT-2385) is a potent, selective, and orally active antagonist of HIF2α, binds to HIF2α PAS-B domain (Kd=50 nM) and disrupts HIF2α/ARNT dimer formation.
